Skip to content

Trexo Theo

by Trexo Robotics Inc.

510(k) K254198

Trexo Theo is a medical device (FDA Class II; FDA product code PHL, Powered Exoskeleton) made by Trexo Robotics Inc., cleared under FDA 510(k) K254198 on 2 Sep 2026, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK254198 Date2 Sep 2026ClearedStatusActive

Official records

From the FDA record

Received by the FDA
23 Dec 2025
FDA decision
2 Sep 2026 (Substantially Equivalent)
FDA review time
253 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K254198 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PHL
FDA applicant
Trexo Robotics, Inc.
Device class
Class II
Regulation
21 CFR Part 890.3480
Advisory committee
Physical Medicine
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code PHL (Powered Exoskeleton).

Other devices from Trexo Robotics Inc.

See all devices from Trexo Robotics Inc. →